{"result": "(\"entity\"<|>FRAILTY<|>EVENT<|>Frailty is a clinical syndrome characterized by decreased reserve and resistance to stressors, leading to increased vulnerability in older adults.)\n##\n(\"entity\"<|>SARCOPENIA<|>EVENT<|>Sarcopenia is the loss of muscle mass and strength associated with aging, which is a significant factor in frailty.)\n##\n(\"entity\"<|>ALBACETE<|>GEO<|>Albacete is a province in Spain where the FRADEA study on frailty and dependence is conducted.)\n##\n(\"entity\"<|>VITAMINA D<|>ORGANIZATION<|>Vitamin D is a nutrient that plays a crucial role in bone health and may be important in the treatment of frailty.)\n##\n(\"entity\"<|>POLIFARMACIA<|>EVENT<|>Polifarmacia refers to the use of multiple medications by a patient, which can complicate the treatment of frailty in older adults.)\n##\n(\"entity\"<|>ACTIVIDAD FÍSICA<|>EVENT<|>Physical activity is a key component in the treatment and prevention of frailty among older adults.)\n##\n(\"entity\"<|>SUPLEMENTACIÓN CALÓRICO-PROTEICA<|>EVENT<|>Caloric-protein supplementation is an intervention aimed at improving nutritional status in frail elderly individuals.)\n##\n(\"relationship\"<|>FRAILTY<|>SARCOPENIA<|>Sarcopenia is a contributing factor to the clinical syndrome of frailty in older adults.<|>8)\n##\n(\"relationship\"<|>ALBACETE<|>FRADEA STUDY<|>The FRADEA study is conducted in Albacete, focusing on frailty and dependence in older adults.<|>9)\n##\n(\"relationship\"<|>VITAMINA D<|>FRAILTY<|>Vitamin D supplementation is considered a treatment option for addressing frailty in older adults.<|>7)\n##\n(\"relationship\"<|>POLIFARMACIA<|>FRAILTY<|>Polifarmacia can complicate the management of frailty in older adults due to potential drug interactions.<|>6)\n##\n(\"relationship\"<|>ACTIVIDAD FÍSICA<|>FRAILTY<|>Physical activity is essential for preventing and treating frailty in older adults.<|>8)\n##\n(\"relationship\"<|>SUPLEMENTACIÓN CALÓRICO-PROTEICA<|>FRAILTY<|>Caloric-protein supplementation is a recommended intervention for improving frailty in older adults.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: aquí, nuevas estrategias de investigación y desarrollo están en marcha,\ndestacando los receptores selectivos de andrógenos, enobosarm (SARM,                      nonste-\nroidal selective androgen receptor modulator), aún en fase de investigación. El uso\nde inhibidores de la enzima convertidora de angiotensina en mujeres disminuye el\ngrado de deterioro de la fuerza y velocidad, aunque no ha demostrado suficiente\nevidencia para su uso.                                                                             27\n\n\n\n– CONCLUSIONES\n         Fragilidad física es un síndrome clínico tratable y reversible.\n         El cribaje debe realizarse a toda población mayor de 70 años sin evidencia\n        de deterioro funcional, que ha sufrido pérdida de peso en el último año en\n        relación a la patología médica que padece.\n         Disponemos de herramientas diagnósticas fiables y consensuadas.\n         El tratamiento integral se sustenta en cuatro pilares: actividad física, suple-\n        mentación calórico-proteica, vitamina D y control estricto de la polifarmacia,\n        además de las posibles causas médicas tratables.\n---\nEnvejecimiento y NutriciónPAUTAS DE INTERVENCIÓN NUTRICIONAL EN ANCIANO FRÁGIL\n\n\n\n                        Los ejercicios de resistencia han demostrado evidencia clínica en fragilidad.\n                        Este enfoque y tratamiento reducirá el riesgo o nivel de deterioro funcional\n                        en la persona mayor.\n              La evolución hacia una definición consensuada del síndrome de fragilidad, enten-\n              dida como fragilidad física presente antes de la aparición de deterioro funcional,\n              abre las puertas a nuevos interrogantes. Antes de ello y de decidir un mecanismo\n              de actuación ante la fragilidad, de pensar si sería necesario adaptar los servicios de\n              atención al anciano, o quién y cómo debe realizarse un programa de detección e\n              intervención precoz, necesitaremos expertos en el manejo de déficits y problemas\n              específicos del anciano.\n\n\n\n              – BIBLIOGRAFÍA RECOMENDADA\n              Abizanda Soler P. Update on frailty. Rev Esp Geriatr Gerontol 2010; 45:106-10.\n              Abizanda Soler P, López-Torres Hidalgo J, Romero Rizos L, et al. Frailty and dependence in\n              Albacete (FRADEA study): reasoning, design and methodology. Rev Esp Geriatr Gerontol\n              2011; 46:81-8.\n              Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013;\n              381:752-62.\n              Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Y, et al. Zamboni, Sarcopenia: European consensus\n              on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older\n              People. Age ageing 2010; 39:412-23.\n              Drubbel I, Numans ME, Kranenburg G, et al. Screening for frailty in primary care: a system-\n              atic review of the psychometric properties of the frailty index in community-dwelling older\n              people. BMC Geriatr 2014; 14:27.\n              Ellis G, Whitehead MA, Robinson D, et al. Comprehensive geriatric assessment for older\n              adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 2011;\n              343:d6553.\n              Ensrud KE, Ewing SK, Taylorn BC, et al. Frailty and risk of falls, fracture, and mortality in older\n  28          women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007; 62:744-51.\n              Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at\n              preventing or delaying functional decline and disability in frail, older persons: a consensus\n              report. J Am Geriatrics Soc 2004; 52:625-34.\n              Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation\n              for physical frailty in very elderly people. N Engl J Med 1995; 330:1.769-75.\n              Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comor-\n              bidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;\n              59:255-63.\n              Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype.\n              J Gerontol A Biol Sci Med Sci 2001; 56:M146-56.\n              Gordon AL, Masud T, Gladman JR. Now that we have a definition for physical frailty, what\n              shape should frailty medicine take? Age Ageing 2014; 43:8-9.\n---\nJones DM, Song X, RockwoodK. Operationalizing a frailty index from a standardized com-\nprehensive geriatric assessment. J Am Geriatr Soc\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ABIZANDA SOLER P.<|>PERSON<|>Abizanda Soler P. is an author who has contributed to research on frailty in elderly people.)\n##\n(\"entity\"<|>LOPEZ-TORRES HIDALGO J.<|>PERSON<|>López-Torres Hidalgo J. is an author involved in the FRADEA study on frailty and dependence in Albacete.)\n##\n(\"entity\"<|>ROMERO RIZOS L.<|>PERSON<|>Romero Rizos L. is a co-author of studies related to frailty in older adults.)\n##\n(\"entity\"<|>CLEG A.<|>PERSON<|>Clegg A. is a researcher who has published work on frailty in elderly people.)\n##\n(\"entity\"<|>Y.<|>PERSON<|>Y. is a co-author in the European consensus on sarcopenia definition and diagnosis.)\n##\n(\"entity\"<|>CRUZ-JENTOFT A.J.<|>PERSON<|>Cruz-Jentoft A.J. is a researcher who has contributed to the understanding of sarcopenia in older people.)\n##\n(\"entity\"<|>DRUBBEL I.<|>PERSON<|>Drubbel I. is an author who has conducted systematic reviews on screening for frailty in primary care.)\n##\n(\"entity\"<|>ELLIS G.<|>PERSON<|>Ellis G. is a researcher who has worked on comprehensive geriatric assessment for older adults.)\n##\n(\"entity\"<|>ENSRUD K.E.<|>PERSON<|>Ensrud K.E. is a researcher studying frailty and its risks in older women.)\n##\n(\"entity\"<|>FERRUCCI L.<|>PERSON<|>Ferrucci L. is a researcher focused on preventing functional decline in frail older persons.)\n##\n(\"entity\"<|>FIATARONE M.A.<|>PERSON<|>Fiatarone M.A. is an author who has researched exercise training and nutritional supplementation for physical frailty.)\n##\n(\"entity\"<|>FRIED L.P.<|>PERSON<|>Fried L.P. is a researcher who has contributed significantly to the understanding of frailty in older adults.)\n##\n(\"entity\"<|>GORDON A.L.<|>PERSON<|>Gordon A.L. is a researcher discussing the implications of frailty definitions in medicine.)\n##\n(\"entity\"<|>FRADEA STUDY<|>EVENT<|>The FRADEA study investigates frailty and dependence in Albacete, focusing on older adults.)\n##\n(\"entity\"<|>AGE AGEING<|>ORGANIZATION<|>Age Ageing is a journal that publishes research related to aging and frailty.)\n##\n(\"entity\"<|>J AM GERIATR SOC<|>ORGANIZATION<|>The Journal of the American Geriatrics Society publishes research on geriatric medicine, including frailty.)\n##\n(\"entity\"<|>NUTRICIÓN<|>ORGANIZATION<|>Nutrición is a field of study focusing on dietary needs and interventions for older adults.)\n##\n(\"relationship\"<|>ABIZANDA SOLER P.<|>FRADEA STUDY<|>Abizanda Soler P. is a contributor to the FRADEA study on frailty and dependence in Albacete.<|>8)\n##\n(\"relationship\"<|>LOPEZ-TORRES HIDALGO J.<|>FRADEA STUDY<|>López-Torres Hidalgo J. is a co-author of the FRADEA study.<|>8)\n##\n(\"relationship\"<|>ROMERO RIZOS L.<|>FRADEA STUDY<|>Romero Rizos L. is involved in the FRADEA study on frailty.<|>8)\n##\n(\"relationship\"<|>CLEG A.<|>AGE AGEING<|>Clegg A. has published research on frailty in the journal Age Ageing.<|>7)\n##\n(\"relationship\"<|>Y.<|>CRUZ-JENTOFT A.J.<|>Y. is a co-author with Cruz-Jentoft A.J. on sarcopenia research.<|>6)\n##\n(\"relationship\"<|>DRUBBEL I.<|>AGE AGEING<|>Drubbel I. has published work related to frailty in the journal Age Ageing.<|>7)\n##\n(\"relationship\"<|>ELLIS G.<|>J AM GERIATR SOC<|>Ellis G. has contributed to research published in the Journal of the American Geriatrics Society.<|>7)\n##\n(\"relationship\"<|>ENSRUD K.E.<|>AGE AGEING<|>Ensrud K.E. has published findings on frailty in the journal Age Ageing.<|>7)\n##\n(\"relationship\"<|>FERRUCCI L.<|>J AM GERIATR SOC<|>Ferrucci L. has published research in the Journal of the American Geriatrics Society.<|>7)\n##\n(\"relationship\"<|>FIATARONE M.A.<|>AGE AGEING<|>Fiatarone M.A. has published studies on frailty in the journal Age Ageing.<|>7)\n##\n(\"relationship\"<|>FRIED L.P.<|>AGE AGEING<|>Fried L.P. has contributed to the journal Age Ageing with research on frailty.<|>7)\n##\n(\"relationship\"<|>GORDON A.L.<|>AGE AGEING<|>Gordon A.L. has discussed frailty medicine in the journal Age Ageing.<|>6)\n<|COMPLETE|>"}]}